Eyevance Pharmaceuticals acquires global rights for Nexagon from OcuNexus Therapeutics

Eyevance Pharmaceuticals has made a significant move in the ophthalmic drug market by acquiring the global licensing rights for Nexagon, an advanced antisense oligomer drug, ... Read More